SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-201695
Filing Date
2018-06-25
Accepted
2018-06-25 07:30:38
Documents
5
Period of Report
2018-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d373982d8k.htm 8-K 25437
2 EX-10.1 d373982dex101.htm EX-10.1 206429
3 EX-10.2 d373982dex102.htm EX-10.2 195609
4 EX-99.1 d373982dex991.htm EX-99.1 6889
5 GRAPHIC g373982g16k36.jpg GRAPHIC 6249
  Complete submission text file 0001193125-18-201695.txt   444756
Mailing Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 19 FIRSTFIELD ROAD GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 18916004
SIC: 2834 Pharmaceutical Preparations